ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,704,000 | -30.2% | 116,376 | -0.6% | 0.01% | -25.0% |
| Q2 2015 | $6,741,000 | -73.8% | 117,136 | -71.1% | 0.01% | -76.5% |
| Q1 2015 | $25,762,000 | +13.3% | 404,622 | +9.9% | 0.03% | +13.3% |
| Q4 2014 | $22,733,000 | +73.7% | 368,206 | +9.2% | 0.03% | +66.7% |
| Q3 2014 | $13,090,000 | +13.3% | 337,105 | +0.5% | 0.02% | +12.5% |
| Q2 2014 | $11,556,000 | -13.8% | 335,453 | +8.1% | 0.02% | -15.8% |
| Q1 2014 | $13,408,000 | +9.0% | 310,292 | +0.5% | 0.02% | +5.6% |
| Q4 2013 | $12,305,000 | +3.7% | 308,852 | -2.3% | 0.02% | -10.0% |
| Q3 2013 | $11,866,000 | +48.5% | 316,098 | +6.3% | 0.02% | +42.9% |
| Q2 2013 | $7,990,000 | – | 297,376 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |